SRA
Summit Rock Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-34,100
| Closed | -$288K | – | 8 |
|
|
2022
Q2 | $288K | Hold |
34,100
| – | – | 0.24% | 7 |
|
|
2022
Q1 | $464K | Hold |
34,100
| – | – | 0.28% | 5 |
|
|
2021
Q4 | $671K | Hold |
34,100
| – | – | 0.4% | 5 |
|
|
2021
Q3 | $1.09M | Hold |
34,100
| – | – | 0.65% | 5 |
|
|
2021
Q2 | $1.15M | Hold |
34,100
| – | – | 0.46% | 4 |
|
|
2021
Q1 | $1.28M | Sell |
34,100
-250
| -0.7% | -$9.39K | 0.44% | 6 |
|
|
2020
Q4 | $1.14M | Sell |
34,350
-426
| -1% | -$14.2K | 0.4% | 8 |
|
|
2020
Q3 | $1.28M | Hold |
34,776
| – | – | 0.59% | 5 |
|
|
2020
Q2 | $1.14M | Buy |
+34,776
| New | +$1.14M | 1.07% | 5 |
|